Last news
Mavenir and O2 Telefónica Germany Strengthen Partnership with Multi-Year IMS Contract Extension for Cloud-Native IMS Services

Mavenir and O2 Telefónica Germany Strengthen Partnership with Multi-Year IMS Contract Extension for Cloud-Native IMS Services

Notified -...

Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration

Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration

Notified -...

MROpenEVO at ECR 2025 with an AI-ready upgrade for further enhanced image quality and faster examinations; new system soon available in Georgia

MROpenEVO at ECR 2025 with an AI-ready upgrade for further enhanced image quality and faster examinations; new system soon available in Georgia

Notified -...

OMass Therapeutics appoints Birgitte Volck as Non-Executive Director

OMass Therapeutics appoints Birgitte Volck as Non-Executive Director

Notified -...

ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

Notified -...

Copenhagen Infrastructure Partners acquires Morecambe, a fixed-bottom offshore wind project in the United Kingdom

Copenhagen Infrastructure Partners acquires Morecambe, a fixed-bottom offshore wind project in the United Kingdom

Notified -...

Synchronoss Technologies Announces Fourth Quarter and Full Year 2024 Earnings Call Date

Synchronoss Technologies Announces Fourth Quarter and Full Year 2024 Earnings Call Date

Notified -...

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY(R) (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY(R) (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder

Notified -...

1 ... 98 99 100 101 102 103 104 105 106 ... 822
menu
menu